{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:26:43Z","timestamp":1787794003745,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Familial chilblain lupus (FCL) is a rare, chronic form of cutaneous lupus erythematosus, which is characterized by painful bluish-red inflammatory cutaneous lesions in acral locations. Mutations in <jats:italic>TREX1<\/jats:italic>, <jats:italic>SAMHD1<\/jats:italic> and <jats:italic>STING<\/jats:italic> have been described in FCL patients. Less than 10 <jats:italic>TREX1<\/jats:italic> mutation positive FCL families have been described in the literature.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>Genetic study was performed in a large, nonconsanguineous Chinese family with 13 members over 4 generations affected by chilblain lupus. Whole exome sequencing was performed for the index patient. Significant variant detection was subsequently validated by resequencing using Sanger sequencing in the index patient and other family members. A novel pathogenic mutation <jats:italic>TREX1<\/jats:italic> p.Asp18His was iditified in the index patient. The mutation was present in affected individuals and was absent in non-affected individuals in the familiy.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We present a four-generation Chinese family with FCL caused by a novel heterozygous mutation <jats:italic>TREX1<\/jats:italic> p.Asp18His, which had been reported in a patient with Aicardi\u2013Goutie\u2019res syndrome. This is the first reported Chinese family with FCL based on mutation in <jats:italic>TREX1<\/jats:italic>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12969-020-00423-y","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:03:05Z","timestamp":1586944985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi\u2013Goutie\u2019res syndrome"],"prefix":"10.1186","volume":"18","author":[{"given":"Cuili","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"423_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10067-008-0975-0","volume":"27","author":"CM Hedrich","year":"2008","unstructured":"Hedrich CM, Fiebig B, Hauck FH, Sallmann S, Hahn G, Pfeiffer C, et al. Chilblain lupus erythematosus-a review of literature. Clin Rheumatol. 2008;27:1341.","journal-title":"Clin Rheumatol"},{"key":"423_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1086\/507848","volume":"79","author":"MA Lee-Kirsch","year":"2006","unstructured":"Lee-Kirsch MA, Gong M, Schulz H, R\u00fcschendorf F, Stein A, Pfeiffer C, et al. Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. Am J Hum Genet. 2006;79:731\u20137.","journal-title":"Am J Hum Genet"},{"key":"423_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejmg.2017.09.004","volume":"60","author":"RM Kisla Ekinci","year":"2017","unstructured":"Kisla Ekinci RM, Balci S, Bisgin A, Altintas DU, Yilmaz M. A homozygote TREX1 mutation in two siblings with different phenotypes: chilblains and cerebral vasculitis. Eur J Med Genet. 2017;60:690\u20134.","journal-title":"Eur J Med Genet"},{"key":"423_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00109-007-0199-9","volume":"85","author":"MA Lee-Kirsch","year":"2007","unstructured":"Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. J Mol Med (Berl). 2007;85:531\u20137.","journal-title":"J Mol Med (Berl)"},{"key":"423_CR5","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00415-013-7084-y","volume":"260","author":"K Yamashiro","year":"2013","unstructured":"Yamashiro K, Tanaka R, Li Y, Mikasa M, Hattori N. A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupus. J Neurol. 2013;260:2653\u20135.","journal-title":"J Neurol"},{"key":"423_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/jamadermatol.2014.3438","volume":"151","author":"C G\u00fcnther","year":"2015","unstructured":"G\u00fcnther C, Berndt N, Wolf C, Lee-Kirsch MA. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3\u2032 repair exonuclease 1 (TREX1). JAMA Dermatol. 2015;151:426\u201331.","journal-title":"JAMA Dermatol"},{"key":"423_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1086\/513443","volume":"80","author":"G Rice","year":"2007","unstructured":"Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;80:811\u20135.","journal-title":"Am J Hum Genet"},{"key":"423_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/rheumatology\/kes181","volume":"52","author":"J Abe","year":"2013","unstructured":"Abe J, Izawa K, Nishikomori R, Awaya T, Kawai T, Yasumi T, et al. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome\/familial chilblain lupus. Rheumatology (Oxford). 2013;52:406\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"423_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2133.2012.10813.x","volume":"167","author":"V T\u00fcngler","year":"2012","unstructured":"T\u00fcngler V, Silver RM, Walkenhorst H, G\u00fcnther C, Lee-Kirsch MA. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Gouti\u00e8res syndrome. Br J Dermatol. 2012;167:212\u20134.","journal-title":"Br J Dermatol"},{"key":"423_CR10","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1038\/jid.2012.210","volume":"132","author":"K Sugiura","year":"2012","unstructured":"Sugiura K, Takeichi T, Kono M, Ito Y, Ogawa Y, Muro Y, et al. Severe chilblain lupus is associated with heterozygous missense mutations of catalytic amino acids or their adjacent mutations in the exonuclease domains of 3\u2032-repair exonuclease 1. J Invest Dermatol. 2012;132:2855\u20137.","journal-title":"J Invest Dermatol"},{"key":"423_CR11","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.jaad.2013.04.020","volume":"69","author":"C G\u00fcnther","year":"2013","unstructured":"G\u00fcnther C, Hillebrand M, Brunk J, Lee-Kirsch MA. Systemic involvement in TREX1-associated familial chilblain lupus. J Am Acad Dermatol. 2013;69:e179\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"423_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ajmg.a.33778","volume":"155A","author":"JC Ravenscroft","year":"2011","unstructured":"Ravenscroft JC, Suri M, Rice GI, Szynkiewicz M, Crow YJ. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus. Am J Med Genet A. 2011;155A:235\u20137.","journal-title":"Am J Med Genet A"},{"key":"423_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","volume":"76","author":"N K\u00f6nig","year":"2017","unstructured":"K\u00f6nig N, Fiehn C, Wolf C, Schuster M, Cura Costa E, T\u00fcngler V, et al. Familial chilblain lupus due to a gain-of-function mutation in STING. Ann Rheum Dis. 2017;76:468\u201372.","journal-title":"Ann Rheum Dis"},{"key":"423_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamadermatol.2018.5077","volume":"155","author":"N Zimmermann","year":"2019","unstructured":"Zimmermann N, Wolf C, Schwenke R, L\u00fcth A, Schmidt F, Engel K, et al. Assessment of clinical response to Janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation. JAMA Dermatol. 2019;155:342\u20136.","journal-title":"JAMA Dermatol"},{"key":"423_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10875-015-0147-3","volume":"35","author":"GI Rice","year":"2015","unstructured":"Rice GI, Rodero MP, Crow YJ. Human disease phenotypes associated with mutations in TREX1. J Clin Immunol. 2015;35:235\u201343.","journal-title":"J Clin Immunol"},{"key":"423_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/rheumatology\/ket372","volume":"53","author":"J Abe","year":"2014","unstructured":"Abe J, Nakamura K, Nishikomori R, Kato M, Mitsuiki N, Izawa K, et al. A nationwide survey of Aicardi-Gouti\u00e8res syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study. Rheumatology (Oxford). 2014;53:448\u201358.","journal-title":"Rheumatology (Oxford)"},{"key":"423_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/521373","volume":"81","author":"G Rice","year":"2007","unstructured":"Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J, et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;81:713\u201325.","journal-title":"Am J Hum Genet"},{"key":"423_CR18","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/ajmg.a.33620","volume":"152A","author":"CA Haaxma","year":"2010","unstructured":"Haaxma CA, Crow YJ, van Steensel MA, Lammens MM, Rice GI, Verbeek MM, et al. A de novo p.Asp18Asn mutation in TREX1 in a patient withAicardi-Gouti\u00e8res syndrome. Am J Med Genet A. 2010;152A:2612\u20137.","journal-title":"Am J Med Genet A"},{"key":"423_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.20021553","volume":"197","author":"L Bennett","year":"2003","unstructured":"Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197:711\u201323.","journal-title":"J Exp Med"},{"key":"423_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/gene.2010.73","volume":"12","author":"B Namjou","year":"2011","unstructured":"Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 2011;12:270\u20139.","journal-title":"Genes Immun"},{"key":"423_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2133.1978.tb01935.x","volume":"98","author":"LG Millard","year":"1978","unstructured":"Millard LG, Rowell NR. Chilblain lupus erythematosus (Hutchinson). A clinical and laboratory study of 17 patients. Br J Dermatol. 1978;98:497\u2013506.","journal-title":"Br J Dermatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00423-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-020-00423-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-020-00423-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T23:57:38Z","timestamp":1618444658000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-020-00423-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1186\/s12969-020-00423-y","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"23 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethical committee of The First Affilated Hospital of Xiamen University. Oral informed assent and written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Publication consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}